SWAYZE ERIC (SVP, Research) sold 11.5% of their position (6.18K shares) of IONIS PHARMACEUTICALS INC on the open market
Open‑market sale worth $512.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/2/2026ACC: 0000874015-26-000102
Officer· SVP, Research
Since Jan 2020
+5.81K
Net shares
Net buyer
$512.4K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
11.99K acquired · 6.18K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+11.99K
Price / share
—
Trade value
—
% of position
28.6%
1/29/2026
41.94K→53.93K
Common Stock
Direct
Shares
−6.18K
Price / share
$82.93
Trade value
$512.45K
% of position
11.5%
1/30/2026
53.93K→47.75K
Total
Net shares
+5.81K
Net value
-$512.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/29/2026 | A · Award | +11.99K | — | — | 28.6% | 41.94K | 53.93K |
| Common Stock Direct | 1/30/2026 | S · Sale | −6.18K | $82.93 | $512.45K | 11.5% | 53.93K | 47.75K |
| Total | +5.81K | -$512.45K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned318.00
Total
318.00 indirect318.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 318.00 | Indirect |
| Total | 318.00 | 318.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported